For Patients

For (newly diagnosed) patients

INNODIA brings together diabetes experts from across Europe and is conducting a study in type1 diabetes to discover new factors to predict the risk of developing the disease, and new treatments and ways of preserving insulin production. Getting a more complete view on different ‘biomarkers’, ie factors in your blood, urine or stool, that can predict the development and evolution of type 1 diabetes, is crucial for a better and earlier diagnosis for people at risk to developing the disease as well as for a better follow-up and eventually finding a cure for the patients.

Such biomarkers can by identified by analyzing your blood, urine and stool samples. We are currently recruiting children and adults across Europe aged between 1 and 45 years who have been diagnosed with type 1 diabetes within the previous 6 weeks. Taking part in this study is completely voluntary. If you agree to take part you will be asked to sign a consent form. However, you are free to change your mind and leave the study at any time without giving a reason. If you choose not to take part or you want to leave the study, your future medical treatment and care will not be affected in any way.

The study lasts up to 24 months from when you were diagnosed with T1D. The first visit will need to be within 6 weeks from when you were told you had diabetes and then at 3, 6, 12 and 24 months from diagnosis.

INNODIA has set-up a network of clinical centers where you can participate in the study if you have been recently diagnosed with type 1 diabetes. Just consult the map to find out where your nearest INNODIA center is and get in contact to learn more.

How can i participate?

Newly diagnosed type 1 diabetic patients and their relatives are encouraged to participate in this study by taking contact with one of our Clinical Centers throughout Europe. If you like to take part in this initiative, please consult our map to select a Center most nearby and complete the registration form so we can contact you.

How can I participate to INNODIA?

Listen to DELTA!
How do we want to arrest type 1 diabetes?
Prof. David Dunger - University of Cambridge
Patient Perspective in INNODIA
Olivier Arnaud - JDRF